Cochrane Evidence Synthesis and Methods ►

Omega-3 fatty acid supplementation for distal symmetrical peripheral neuropathy in adults with diabetes mellitus

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To evaluate the benefits and harms of omega-3 polyunsaturated fatty acid (PUFA) supplements as a treatment for DSPN in people with diabetes mellitus compared to placebo or no treatment.

This is a protocol.

Published:

6 July 2023

Authors:

Britten-Jones AC, Calder G, Busija L, Kamel J, Roberts LJ, MacIsaac RJ, Downie LE

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Britten-Jones AC, Calder G, Busija L, Kamel J, Roberts LJ, MacIsaac RJ, Downie LE. Omega-3 fatty acid supplementation for distal symmetrical peripheral neuropathy in adults with diabetes mellitus (Protocol). Cochrane Database of Systematic Reviews 2023, Issue 7. Art. No.: CD014623. DOI: 10.1002/14651858.CD014623.